Filter
416
Text search:
mutation
Featured
Recommendations
57
New Publications
95
Language
Document type
No document type
184
Guidelines
84
Studies & Reports
71
Manuals
24
Strategic & Response Plan
18
Training Material
13
Fact sheets
12
Videos
4
Situation Updates
3
Resource Platforms
2
Brochures
1
Countries / Regions
India
23
Global
12
Western and Central Europe
10
Africa
10
Ethiopia
9
South Africa
9
Cameroon
8
Latin America and the Carribbean
8
Burkina Faso
6
Haiti
6
Germany
6
Nigeria
5
Congo, Democratic Republic of
5
Nepal
5
Senegal
4
Tanzania
4
Benin
4
Namibia
4
Liberia
3
Uganda
3
Zambia
3
Middle East and North Africa
3
Eastern Europe
3
Sierra Leone
2
Mali
2
Morocco
2
Niger
2
Togo
2
Kenya
2
Cambodia
2
Thailand
2
China
2
Rwanda
2
Bangladesh
2
Mozambique
2
Brazil
2
Bolivia
2
Madagascar
2
Myanmar / Burma
2
Asia
2
Russia
2
Vietnam
2
France
2
Guinea
1
Côte d’Ivoire / Ivory Coast
1
Saudi Arabia
1
Zimbabwe
1
Philippines
1
Somalia
1
Iraq
1
Jordan
1
Lebanon
1
Egypt
1
Syria
1
Chad
1
Indonesia
1
Mauritania
1
Malawi
1
Sudan
1
Central African Republic
1
Argentina
1
Dominican Republic
1
Peru
1
Eswatini/ Swaziland
1
Cuba
1
Ukraine
1
Colombia
1
Honduras
1
Ecuador
1
Botswana
1
El Salvador
1
Libya
1
Guatemala
1
Mexico
1
Nicaragua
1
Chile
1
Yemen
1
East and Southern Africa
1
West and Central Africa
1
South–East Asia Region
1
Venezuela
1
Laos
1
Congo-Brazzaville
1
Qatar
1
Kazakhstan
1
Tunisia
1
Spain
1
Belarus
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
128
Clinical Guidelines
49
Public Health
26
Pharmacy & Technologies
12
Key Resources
8
Women & Child Health
6
Capacity Building
3
Annual Report MEDBOX
1
Toolboxes
COVID-19
69
TB
51
HIV
33
Malaria
23
AMR
22
Mental Health
15
Pharmacy
15
NTDs
14
Ebola & Marburg
10
Planetary Health
10
Rapid Response
9
NCDs
9
Refugee
7
Caregiver
6
2.0 Rapid Response
6
Disability
4
Polio
2
Zika
2
Natural Hazards
1
Specific Hazards
1
Health Financing Toolbox
1
Le guide décrit les étapes essentielles et donne des orientations aux pays pour l’adoption et le déploiement du c-TPIg de manière à l’intégrer dans le système de santé existant. Il s’appuie sur les meilleures pratiques et les enseignements tirés des expériences pilotes dans 8 pays af
...
Trop. Med. Infect. Dis. 2022, 7, 152. https://doi.org/10.3390/tropicalmed7080152
WHO recommends artemisinin-based combination therapies for treating uncomplicated malaria, alongside studies to monitor treatment effectiveness. Given the threat of antimalarial resistance, including partial resistance in several African countries, molecular tools are vital for tracking resistance.
...
Meeting report, Kampala, Uganda,
7–8 November 2023
Fragile Beginnings. The Fragile Beginnings series examines the growing body of research on the unique vulnerabilities of children: in utero and at birth, during infancy and childhood and throughout adolescence. Its purpose is to enable evidence-based advocacy and action on children’s environmental
...
Le Plan Stratégique National de Lutte contre le Paludisme 2023–2026 du Togo définit les grandes orientations pour réduire de 65 % l’incidence et la mortalité liées au paludisme d’ici 2026, en comparaison avec les niveaux de 2022. Élaboré par le Programme National de Lutte contre le Pa
...
The framework recommends expanded coverage of malaria diagnostic and treatment services, intensified vector control to drive down transmission, strengthened malaria surveillance, and increased transborder collaboration, especially in terms of efforts to control the sale and use of artemisinin monoth
...
Offering additional pre-exposure prophylaxis (PrEP) choices has the potential to increase uptake and effective use of PrEP, and of HIV prevention overall, as it allows people to choose a method that they prefer.
In this guideline, WHO recommends an offering long-acting injectable lenacapavir (LEN
...
Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis. Web Annex B
Le Plan Stratégique National de Lutte contre le Paludisme au Cameroun 2019–2023 vise à réduire l’incidence et la mortalité liées au paludisme dans tout le pays, en mettant l’accent sur les groupes les plus vulnérables comme les enfants de moins de 5 ans et les femmes enceintes. Il repose
...
The annual bulletin of the Mekong Malaria Elimination (MME) programme is a yearly report that reviews ongoing efforts to combat multidrug resistance and eliminate malaria in the 6 countries of the Greater Mekong subregion (GMS): Cambodia, China (Yunnan province), Lao People's Democratic Republic, My
...
This brief report summarizes recent information on HIV drug resistance (HIVDR) in the era of integrase-strand transfer inhibitors (INSTI) for HIV prevention and treatment.
Developed through broad and inclusive consultation, and aligned with the WHO Global Health Sector Strategies and the Sustainable Development Goals, the framework promotes a people-centred approach and antimicrobial stewardship across 5 key domains: prevention and response, surveillance, research and
...
ATIC Newsletter, Vol 15, Issue 1,
February 2022.
World malaria report 2025. Excecutive Summary
recommended
Addressing the threat of antimalarial drug resistance. This year’s report spotlights the growing threat of antimalarial drug resistance. Partial resistance to artemisinin derivatives – the backbone of malaria treatments after failures of chloroquine and sulfadoxine-pyrimethamine – has now b
...
Malgré ces progrès, le paludisme reste toutefois un problème de santé mondial important, avec environ 282 millions de cas et 610 000 décès en 2024, soit environ 9 millions de cas de plus que l'année précédente. La région Afrique de l'OMS continue de supporter la plus grande partie du farde
...